Here are six updates on GI companies from the past week.
Vizient bestowed its 2017 Innovative Technology designation on Pentax Medical's slim linear ultrasound endoscope.
Valeant CEO Joseph Papa said the company intends to pay down an additional $125 million in senior secured term loans with cash on hand.
Takeda reported net revenues of $881.4 billion yen ($7.71 billion) in its third quarter fiscal year 2017 results.
CapsoVision earned a CE Mark for its CapsoCam Plus System for patients 2 years old and older.
Boston Scientific reported net sales of $2.22 billion in its third quarter fiscal year 2017 results.
U.S.-based gastroenterologists once again selected IM HealthScience's IBgard as their No. 1 recommended peppermint oil for IBS, according to a QuintilesIMS survey.